Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) traded up 3.2% during mid-day trading on Monday . The company traded as high as C$0.64 and last traded at C$0.64. 2,020 shares changed hands during trading, a decline of 91% from the average session volume of 22,788 shares. The stock had previously closed at C$0.62.
Crescita Therapeutics Stock Performance
The company has a market cap of C$12.40 million, a price-to-earnings ratio of -4.27 and a beta of 1.69. The stock’s fifty day simple moving average is C$0.59 and its two-hundred day simple moving average is C$0.55. The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.29 and a current ratio of 3.37.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Featured Stories
- Five stocks we like better than Crescita Therapeutics
- What is the S&P/TSX Index?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- The Role Economic Reports Play in a Successful Investment Strategy
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What are earnings reports?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
